Bioventix PLC (LON:BVXP – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 3,200 ($41.50) and last traded at GBX 3,278 ($42.51), with a volume of 46083 shares. The stock had previously closed at GBX 3,600 ($46.69).
Bioventix Trading Up 4.3 %
The stock has a fifty day simple moving average of GBX 3,917.66 and a two-hundred day simple moving average of GBX 4,189.51. The company has a market cap of £175.65 million, a PE ratio of 2,105.52 and a beta of 0.35.
Bioventix Increases Dividend
The firm also recently disclosed a dividend, which will be paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th will be given a GBX 87 ($1.13) dividend. This is a boost from Bioventix’s previous dividend of $68.00. The ex-dividend date of this dividend is Thursday, November 7th. This represents a yield of 2.4%. Bioventix’s dividend payout ratio is presently 9,693.25%.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Read More
- Five stocks we like better than Bioventix
- 3 Healthcare Dividend Stocks to Buy
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How to Choose Top Rated Stocks
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Stock Market Sectors: What Are They and How Many Are There?
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
